| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
AstraZeneca set to receive up to $780 million for Horizons takeover of Viela
StockMarketWire.com
|
AstraZeneca has agreed to sell its 26.7% stake in Viela Bio as part of the proposed acquisition of Viela by Dublin-based Horizon Therapeutics.
AstraZeneca is expecting to receive cash proceeds and profit of around $760-$780 million for the sale of the holding.
The deal is expected to complete by the end of the first quarter of 2021.
Maryland-based Viela, which develops medicines for inflammation and autoimmune diseases, was founded in 2018 as a spinoff from AstraZeneca.
At 1:12pm: (LON:AZN) Astrazeneca PLC share price was 0p at 8633p
Story provided by StockMarketWire.com
|
|
|
|
|
|
